References
Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Chapurlat RD, Boonen S, Anderson FA Jr, Adami S, Adachi JD, Investigators GLOW (2014) Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res 29:487–493
De Luis DA, Aller R, Izaola O, Bachiller R (2015) Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients. J Endocrinol Invest 38:143–147
Berezin AE, Kremzer AA, Samura TA, Berezina TA, Kruzliak P (2015) Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J Endocrinol Invest 38:865–874
Chen XX, Yang T (2015) Roles of leptin in bone metabolism and bone diseases. J Bone Miner Metab 33:474–485
Sawicka K, Krasowska D (2016) Adipokines in connective tissue diseases. Clin Exp Rheumatol (Epub ahead of print)
Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Minisola S, D’ Erasmo E, Mazzuoli GF, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56:30–36
Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S (2014) Vitamin d and its relationship with obesity and muscle. Int J Endocrinol 2014:841248
Upala S, Sanguankeo A, Jaruvongvanich V (2015) Association between nonalcoholic fatty liver disease and bone mineral density: a systematic review and meta-analysis. J Endocrinol Invest 38:931–932
Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2703–2713
Arama V, Munteanu DI, Streinu Cercel A, Ion DA, Mihailescu R, Tiliscan C, Tudor AM, Arama SS (2014) Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin. J Endocrinol Invest 37:533–539
Li XP, Zeng S, Wang M, Wu XP, Liao EY (2014) Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area. J Endocrinol Invest 37:991–1000
Menzel J, Di Giuseppe R, Biemann R, Aleksandrova K, Kuxhaus O, Wittenbecher C, Fritsche A, Schulze MB, Isermann B, Boeing H, Weikert C (2016) Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. J Endocrinol Invest. doi:10.1007/s40618-016-0544-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
The articles reviewed had compliance with ethical standards, and the Researches involving human participants obtained the informed consent.
Rights and permissions
About this article
Cite this article
Pepe, J., Cipriani, C., Cilli, M. et al. Adipokines and bone metabolism: an interplay to untangle. J Endocrinol Invest 39, 1359–1361 (2016). https://doi.org/10.1007/s40618-016-0549-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-016-0549-y